Business
Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates
Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the Americ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em !IMPORTANT\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n April 4, 2024\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company\n \n \n – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company's booth. The Company also announced the grant of certain stock options and the engagement of Velocity Trade Capital Ltd. (\"Velocity Trade\") for market liquidity services.\n \n \n \n Conference Details\n \n \n \n #ASBRS24 -\n \n The American Society of Breast Surgeons 25\n \n th\n \n Annual Meeting\n \n \n \n \n April 10-14, 2024\n \n \n \n Orlando World Center Marriott;\n \n Orlando, FL\n \n \n \n Booth #229 – Perimeter Medical Imaging AI\n \n \n \n Adrian Mendes\n \n , Perimeter's Chief Executive Officer stated, \"We are excited to have a presence at ASBrS this year alongside top companies in the breast oncology space, providing us with an opportunity to network with 1,700 medical professionals from the U.S. and 27 countries. We believe combining a surgeon's clinical expertise with OCT technology can provide margin insights real-time during surgeries, which gives them clarity to act in the moment and close with confidence.\"\n \n \n \n Issuance of Stock Options\n \n \n \n On\n \n April 3, 2024\n \n , the Company approved the grant of 470,000 stock options to certain directors and company officers, and 863,177 options to employees as a key retention incentive tool. Each stock option entitles the holder to acquire one common share of the Company at an exercise price of\n \n $0.85\n \n per common share and expires 10 years from...